Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN2,Alpha-actinin-2,43292,293,1.38 [1.18-1.62],6.031932637680089e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,51651,329,0.69 [0.56-0.86],0.0006473977267382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK,Neuroblast differentiation-associated protein AHNAK,43572,301,0.59 [0.41-0.85],0.0048770025995411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AREG,Amphiregulin,51256,329,1.33 [1.09-1.64],0.0060533292808853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART3,Ecto-ADP-ribosyltransferase 3,51698,331,0.52 [0.40-0.69],3.401874627580291e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA14,Carbonic anhydrase 14,51932,332,0.65 [0.50-0.86],0.0021392500118669
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA3,Carbonic anhydrase 3,52044,332,1.38 [1.19-1.59],2.106138191513333e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPN3,Calpain-3,44551,301,1.46 [1.18-1.80],0.0004709561510395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN3,CCN family member 3,52043,334,1.44 [1.10-1.89],0.0078472629395582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCND2,G1/S-specific cyclin-D2,43946,299,0.65 [0.52-0.82],0.0003126009275288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD248,Endosialin,44764,304,0.57 [0.43-0.74],3.607011252644702e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD276,CD276 antigen,51461,329,1.72 [1.30-2.27],0.0001301887594465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP290,Centrosomal protein of 290 kDa,43946,299,0.71 [0.56-0.92],0.0091302525120055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFC1,Cryptic protein,50282,316,0.73 [0.57-0.92],0.0086823279164807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4G,C-type lectin domain family 4 member G,51419,328,1.48 [1.10-1.97],0.0084739973110237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO6,Coronin-6,43318,298,1.47 [1.15-1.87],0.0018663745656956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA1,Carboxypeptidase A1,52128,334,0.80 [0.69-0.94],0.005949743371796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSRP3,Cysteine and glycine-rich protein 3,43292,293,1.28 [1.17-1.40],5.0577556231116614e-08
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTNB,Dystrobrevin beta,44466,301,1.49 [1.19-1.87],0.000471900739017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDA2R,Tumor necrosis factor receptor superfamily member 27,51932,332,1.82 [1.45-2.29],3.590271438899539e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFLAM,Pikachurin,44569,304,0.44 [0.30-0.65],3.3152410596852895e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,51847,331,0.62 [0.44-0.86],0.0042969525255025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP1,"Fatty acid-binding protein, liver",51461,329,0.86 [0.77-0.96],0.0054104931417268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP3,"Fatty acid-binding protein, heart",44759,302,1.37 [1.13-1.67],0.0012110592447381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP3,Fibroblast growth factor-binding protein 3,44654,304,0.67 [0.50-0.91],0.0095126398834746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,51932,332,0.53 [0.37-0.76],0.0006439331573572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA1,GDNF family receptor alpha-1,51855,330,1.67 [1.20-2.32],0.0021590014372974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,43466,294,1.79 [1.34-2.40],9.057610874387088e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA2,Heat shock-related 70 kDa protein 2,44551,301,1.49 [1.16-1.92],0.001775863354794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB6,Heat shock protein beta-6,51932,332,1.79 [1.44-2.24],2.658698344618989e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL25,Interleukin-25,43008,294,0.63 [0.46-0.87],0.0052312918964138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAM,Integrin alpha-M,51506,328,0.57 [0.42-0.78],0.0004773416572691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAV,Integrin alpha-V,51932,332,0.52 [0.34-0.78],0.0016997440279808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB2,Integrin beta-2,51199,329,0.54 [0.38-0.77],0.0006225770927096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB5,Integrin beta-5,51651,329,0.68 [0.52-0.89],0.0047182180058892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCP1,Plastin-2,44764,304,0.71 [0.56-0.91],0.0070384016616147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEG1,Protein LEG1 homolog,42296,281,0.74 [0.62-0.89],0.0010653398735604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MB,Myoglobin,52128,334,1.46 [1.25-1.71],2.562936078851317e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF10,Multiple epidermal growth factor-like domains protein 10,51461,329,1.87 [1.46-2.39],5.304681610660552e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP9,Matrix metalloproteinase-9,51422,328,1.24 [1.06-1.46],0.0082373430698508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC1,"Myosin-binding protein C, slow-type",44759,302,1.48 [1.30-1.68],3.394016314653506e-09
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC2,"Myosin-binding protein C, fast-type",43572,301,1.18 [1.06-1.31],0.003233650679319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL3,Myosin light chain 3,43572,301,1.40 [1.22-1.61],2.747863233057484e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",43533,300,1.46 [1.25-1.71],2.4762940530707364e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM2,Myomesin-2,43292,293,1.44 [1.20-1.71],5.755060054693291e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM3,Myomesin-3,43784,299,1.41 [1.26-1.58],3.951534830120508e-09
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAN,Neurocan core protein,51944,331,0.65 [0.51-0.84],0.0009709289471716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEB,Nebulin,43292,293,1.39 [1.10-1.75],0.0053568500486692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEFL,Neurofilament light polypeptide,50129,321,3.06 [2.74-3.42],4.470843460458548e-87
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL2,Protein kinase C-binding protein NELL2,51715,329,0.52 [0.37-0.74],0.0002852187973136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFASC,Neurofascin,52056,330,0.62 [0.44-0.89],0.0085427299338439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS1,"Nitric oxide synthase, brain",50288,323,1.26 [1.06-1.50],0.0083548358728054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLR1,Oxidized low-density lipoprotein receptor 1,50992,321,1.22 [1.05-1.42],0.0098300908938098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC1,Plexin domain-containing protein 1,50282,316,0.55 [0.38-0.79],0.0013518375331466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP1,Inactive pancreatic lipase-related protein 1,44654,304,0.83 [0.72-0.95],0.0079683424045264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRRT3,Proline-rich transmembrane protein 3,43572,301,0.65 [0.49-0.88],0.0050321695363469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBFOX3,RNA binding protein fox-1 homolog 3,44680,305,1.59 [1.29-1.97],1.8925026755953653e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP2,Retinol-binding protein 2,51256,329,0.81 [0.71-0.93],0.0019002547700002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF31,E3 ubiquitin-protein ligase RNF31,43466,294,0.57 [0.39-0.83],0.0038152621723895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELE,E-selectin,52128,334,0.76 [0.63-0.91],0.0034047051655721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK1,SLIT and NTRK-like protein 1,43466,294,0.56 [0.40-0.80],0.0012484970845046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORBS1,Sorbin and SH3 domain-containing protein 1,44680,305,1.46 [1.22-1.75],4.2817454947217045e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS4,Thrombospondin-4,51530,331,1.46 [1.18-1.80],0.0004821914502988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC5D,Netrin receptor UNC5D,43466,294,0.55 [0.35-0.86],0.00831497867278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10,V-set and immunoglobulin domain-containing protein 10,44551,301,0.62 [0.43-0.89],0.0099895063291291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA5A,von Willebrand factor A domain-containing protein 5A,43160,294,0.75 [0.62-0.91],0.0042278545214685
